Related Experiment Video
Updated: Mar 3, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
[Change of cardiovascular risk factors after eradication therapy of Helicobacter pylori]
S Hishiki1, T Shiwa, T Yokoyama
1Department of Gastroenterology, Japanese Red Cross Hospital Omori.
Abstract:
We studied the effect of eradication of Helicobacter pylori (H.P.) on several cardiovascular risk factors in patients with peptic ulcer disease. 205 H.P.-positive patients with peptic ulcer disease were successfully eradicated. Body weight (BW), body mass index (BMI), total cholesterol (TC), triglycerides (TG). LDL-cholesterol (LDL), HDL-cholesterol, gamma-GTP, uric acid and plasma glucose of those were measured before eradication, one year after, and two years after eradication. As a control, same parameters were measured in 430 subjects without gastroenterological disease including both H.P.-positives and H.P.-negatives. Those eradicated patients showed a significant increase in BW, BMI, TC, LDL, TG and gamma-GTP over the first one year and two years after eradication. No significant difference of any parameters were observed between control groups both with and without H.P. No significant difference was observed over one year in both control groups. It is suggested that those cardiovascular risk factors should be regarded carefully to prevent the acceleration of life-style disease after H.P. eradication therapy.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

